Clinical trial

An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache

NCT00531895

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record duloxetine Normalized identity: duloxetineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-04-01

PhasePHASE4

Conditions

Major Depressionverified · MONDO: major depressive disorder

Chronic Primary Headacheunresolved

Interventions

duloxetineDRUG · verified · RxNorm: duloxetine

Sponsors & collaborators

Kraepelin Psiquiatria Clinicalead sponsor

Eli Lilly and Companycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00531895 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.